中国血液净化

中国血液净化 ›› 2020, Vol. 19 ›› Issue (07): 482-491.doi: 10.3969/j.issn.1671-4091.2020.07.013

• 指南解读 • 上一篇    下一篇

2019版KDOQI 血管通路临床实践指南解读

周洁1,陈冬平1,叶朝阳1   

  1. 1上海中医药大学附属曙光医院肾病科
  • 收稿日期:2020-05-06 修回日期:2020-03-18 出版日期:2020-07-12 发布日期:2020-07-03
  • 通讯作者: 叶朝阳 yechaoyang63@126.com E-mail:yechaoyang63@126.com
  • 基金资助:
    上海市进一步加快中医药事业发展三年行动计划(2018 年-2020年)资助[ZY(2018-2020)-CCCX-2003-08,ZY(2018-2020)-FWTX-7005]

Interpretation of the KDOQI Clinical Practice Guideline for Vascular Access, 2019 version

  1.  1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2020-05-06 Revised:2020-03-18 Online:2020-07-12 Published:2020-07-03

PDF

2119

摘要： 【摘要】2020 年4 月，美国肾脏基金会对肾脏病生存质量指导(kidney disease outcomes quality initiative,KDOQI)血管通路指南做了1 次重大更新，围绕终末期肾病患者生存计划开展各项治疗，内容包括终末期肾病患者的生命规划、血管通路的选择、特定并发症处理的新方法等。本文结合我国国情，对本指南进行解读，指导医生和患者共同对终末期肾病的治疗模式和血管通路做出决策，并为后续研究带来方向性的建议。

关键词: 肾脏病生存质量指导血管通路临床实践指南, 更新, 生命规划

Abstract: 【Abstract】In April 2020, the American National Kidney Foundation made a major update to the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guideline for Vascular Access, and carried out various treatments for the survival plan of end-stage renal disease patients, including the life plan of end-stage renal disease patients, the selection of vascular access, and the new methods for handling specific complications. This article interprets this guideline according to the conditions of our country, helps doctors and patients make decisions on the treatment mode and vascular access for end-stage renal disease, and brings
directional suggestions for subsequent research.

Key words: KDOQI Clinical Practice Guideline for Vascular Access, Update, Life-plan

中图分类号: